Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
J Pharmacol Exp Ther. 2011 Feb;336(2):356-64. doi: 10.1124/jpet.110.174763. Epub 2010 Oct 29.
J Pharmacol Exp Ther. 2011.
PMID: 21036912
Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
Metzger JM, Gagen K, Raustad KA, Yang L, White A, Wang SP, Craw S, Liu P, Lanza T, Lin LS, Nargund RP, Guan XM, Strack AM, Reitman ML.
Metzger JM, et al. Among authors: raustad ka.
Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E816-24. doi: 10.1152/ajpendo.00404.2010. Epub 2010 Aug 31.
Am J Physiol Endocrinol Metab. 2010.
PMID: 20807840
Free article.
Item in Clipboard
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
Chobanian HR, Guo Y, Liu P, Chioda M, Lanza TJ Jr, Chang L, Kelly TM, Kan Y, Palyha O, Guan XM, Marsh DJ, Metzger JM, Gorski JN, Raustad K, Wang SP, Strack AM, Miller R, Pang J, Madeira M, Lyons K, Dragovic J, Reitman ML, Nargund RP, Lin LS.
Chobanian HR, et al.
ACS Med Chem Lett. 2012 Jan 21;3(3):252-6. doi: 10.1021/ml200304j. eCollection 2012 Mar 8.
ACS Med Chem Lett. 2012.
PMID: 24900461
Free PMC article.
Item in Clipboard
Cite
Cite